These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11713602)

  • 1. Metabolism and biliary excretion of the novel anticancer agent 10-hydroxycamptothecin in the isolated perfused rat liver.
    Platzer P; Thalhammer T; Reznicek G; Hamilton G; Zhang R; Jäger W
    Int J Oncol; 2001 Dec; 19(6):1287-93. PubMed ID: 11713602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of camptothecin, a potent topoisomerase I inhibitor, in the isolated perfused rat liver.
    Platzer P; Thalhammer T; Hamilton G; Ulsperger E; Rosenberg E; Wissiack R; Jäger W
    Cancer Chemother Pharmacol; 2000; 45(1):50-4. PubMed ID: 10647501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of topotecan in the isolated perfused rat liver: identification of three novel metabolites.
    Platzer P; Schaden S; Thalhammer T; Hamilton G; Rosenberg B; Silgoner I; Jäger W
    Anticancer Res; 1998; 18(4A):2695-700. PubMed ID: 9703931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of UCN-01 in isolated perfused rat liver: role of Mrp2 in the biliary excretion of glucuronides.
    Hagenauer B; Maier-Salamon A; Thalhammer T; Zöllner P; Senderowicz A; Jäger W
    Oncol Rep; 2004 May; 11(5):1069-75. PubMed ID: 15069549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of the anticancer drug flavopiridol, a new inhibitor of cyclin dependent kinases, in rat liver.
    Jäger W; Zembsch B; Wolschann P; Pittenauer E; Senderowicz AM; Sausville EA; Sedlacek HH; Graf J; Thalhammer T
    Life Sci; 1998; 62(20):1861-73. PubMed ID: 9600328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loperamide inhibits the biliary excretion of irinotecan (CPT-11) in the rat isolated perfused liver.
    Tobin PJ; Hong Y; Seale JP; Rivory LP; McLachlan AJ
    J Pharm Pharmacol; 2005 Jan; 57(1):39-45. PubMed ID: 15638991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I.
    Zhang R; Li Y; Cai Q; Liu T; Sun H; Chambless B
    Cancer Chemother Pharmacol; 1998; 41(4):257-67. PubMed ID: 9488594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver.
    Ahmed S; Vo NT; Thalhammer T; Thalhammer F; Gattringer KB; Jäger W
    J Pharm Pharmacol; 2008 Jan; 60(1):55-62. PubMed ID: 18088505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the metabolites of irinotecan, a new derivative of camptothecin, in rat bile and its biliary excretion.
    Atsumi R; Suzuki W; Hakusui H
    Xenobiotica; 1991 Sep; 21(9):1159-69. PubMed ID: 1788984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary excretion of flavopiridol and its glucuronides in the isolated perfused rat liver: role of multidrug resistance protein 2 (Mrp2).
    Jäger W; Gehring E; Hagenauer B; Aust S; Senderowicz A; Thalhammer T
    Life Sci; 2003 Oct; 73(22):2841-54. PubMed ID: 14511769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic metabolism and biliary excretion of valerenic acid in isolated perfused rat livers: role of Mrp2 (Abcc2).
    Maier-Salamon A; Trauner G; Hiltscher R; Reznicek G; Kopp B; Thalhammer T; Jäger W
    J Pharm Sci; 2009 Oct; 98(10):3839-49. PubMed ID: 19156843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of the new ribonucleotide reductase inhibitor amidox in the isolated perfused rat liver.
    Salamon A; Vielnascher E; Hagenauer B; Szekeres T; Szekeres-Fritzer M; Thalhammer T; Jäger W
    Anticancer Res; 2000; 20(5B):3521-6. PubMed ID: 11131656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and disposition of resveratrol in the isolated perfused rat liver: role of Mrp2 in the biliary excretion of glucuronides.
    Maier-Salamon A; Hagenauer B; Reznicek G; Szekeres T; Thalhammer T; Jäger W
    J Pharm Sci; 2008 Apr; 97(4):1615-28. PubMed ID: 17724663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irinotecan (CPT-11) metabolites in human bile and urine.
    Lokiec F; du Sorbier BM; Sanderink GJ
    Clin Cancer Res; 1996 Dec; 2(12):1943-9. PubMed ID: 9816153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and biliary excretion of trimetrexate by the isolated perfused rat liver.
    Webster LK; Tong WP; McCormack JJ
    Cancer Lett; 1985 Oct; 29(1):65-71. PubMed ID: 2933139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and elimination of 5,6-dimethylxanthenone-4-acetic acid in the isolated perfused rat liver.
    Webster LK; Ellis AG; Kestell P; Rewcastle GW
    Drug Metab Dispos; 1995 Mar; 23(3):363-8. PubMed ID: 7628302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of isosteviol in the rat isolated perfused liver.
    Jin H; Wang J; Gerber JP; Davey AK
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):593-7. PubMed ID: 20082626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the metabolites of 9-nitro-20(S)-camptothecin in rats.
    Li K; Chen X; Zhong D; Li Y
    Drug Metab Dispos; 2003 Jun; 31(6):792-7. PubMed ID: 12756214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary excretion mechanism of CPT-11 and its metabolites in humans: involvement of primary active transporters.
    Chu XY; Kato Y; Ueda K; Suzuki H; Niinuma K; Tyson CA; Weizer V; Dabbs JE; Froehlich R; Green CE; Sugiyama Y
    Cancer Res; 1998 Nov; 58(22):5137-43. PubMed ID: 9823324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolism of oestrone and some other steroids in isolated perfused rat and guinea pig livers.
    Roy AB; Curtis CG; Powell GM
    Xenobiotica; 1987 Nov; 17(11):1299-313. PubMed ID: 2963441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.